Skip to main content
. 2020 May 26;17:571–585. doi: 10.1016/j.omto.2020.05.009

Figure 9.

Figure 9

Safety Evaluation of CAR T Cell Therapy

(A) Flow cytometry reveals surface PD-L1 levels in different normal human cell lines. (B–E) Both PD1ACR-T and PDL1CAR-T cells show no cytolytic activity against healthy WS1 (B) and Hs181.Tes (C) cells. Both MRC-5 (D) and Hs67 (E) cell lines are sensitive to PD1ACR-T and PDL1CAR-T cells in vitro (*p< 0.05). Data are presented as the mean ± SD of three independent experiments. (F) H/E staining displays no obvious off-target toxicity against major mice organs. Original magnification, 200X. Scale bars, 100 um.